HIV I Infection Clinical Trial
Official title:
A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe
Following the initiation of Doravirine (DOR) regimen among people living with HIV (PLWH), the study will aim to assess effectiveness, discontinuation, and resistance over the 12-month period. Retrospective data from 400 patients, 100 treatment naïve and 300 virally suppressed patients switching from a 1st or second line treatment, is planned to be collected from 6 - 10 European sites. The study will be conducted through collaboration with the NEAT ID Network, a well-established network of clinical sites across Europe.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04585737 -
Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF
|
Phase 4 | |
| Not yet recruiting |
NCT06282783 -
Studying Topiramate for Re-Activating the HIV-1 Reservoir
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT03622177 -
Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection
|
||
| Recruiting |
NCT05854381 -
To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV
|
Phase 1 | |
| Enrolling by invitation |
NCT05071378 -
Leveraging Family-Based Assets for Black MSM In House Ball Communities
|
N/A | |
| Completed |
NCT04568395 -
Acute Effects of TCIG vs ECIG in PLWH
|
N/A | |
| Recruiting |
NCT04887675 -
Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI
|
N/A | |
| Recruiting |
NCT04820933 -
Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV
|
Early Phase 1 | |
| Completed |
NCT03584048 -
Charlotte Retention in Care Study
|
||
| Recruiting |
NCT06005610 -
Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
|
Phase 2 | |
| Recruiting |
NCT05947890 -
Evaluating the Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living With and Without HIV in South Africa
|
Phase 2 | |
| Recruiting |
NCT05187429 -
Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT05601128 -
A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA
|
Phase 3 | |
| Completed |
NCT04675255 -
Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism
|
N/A | |
| Recruiting |
NCT05110963 -
Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments
|
N/A | |
| Completed |
NCT03986099 -
Community Based Antiretroviral Therapy (CBART) Among Children on Chronic ART
|
N/A | |
| Completed |
NCT04971343 -
Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol
|
||
| Completed |
NCT04725877 -
VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04618198 -
Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa
|
Phase 3 | |
| Completed |
NCT05383456 -
The Visceral Adiposity Measurement and Observation Study
|